Class 2 Medicines recall: Medreich, Ranitidine 150mg Tablets

Medreich Plc is recalling all unexpired stock of the above products from pharmacies and wholesalers as a precautionary measure due to possible contamination with an impurity N-nitrosodimethylamine (NDMA) which has genotoxic and carcinogenic potential.

Loading...

Taking too long?

Reload document

| Open in new tab

Download [176.45 KB]

This circular is being shared under the Open Government Copywrite licence. Whilst we will publish alerts relevant to pharmacists, pharmacy technicians and pharmacy teams we recommend you also keep an eye on the SHOW website and/or the MHRA website.